Alseroxylon

CHEMBL1201454 Phase 4 Approuvé Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

281.8 g/mol

LogP

—

Phase

4

A purified alkaloid fraction from Rauwolfia serpentina plants that depletes catecholamines from nerve endings, lowering blood pressure and heart rate, historically used in hypertension treatment. Like other rauwolfia alkaloids including reserpine, it has largely been replaced by newer antihypertensives with better side effect profiles.

Masse moléculaire

281,8300 g/mol

TPSA

101,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C1C(O1)CCl.C(CNCCNCCNCCN)N

InChI

InChI=1S/C8H23N5.C3H5ClO/c9-1-3-11-5-7-13-8-6-12-4-2-10;4-1-3-2-5-3/h11-13H,1-10H2;3H,1-2H2

Molecular Formula

C11H28ClN5O

HBD / HBA

5 / 6

Liaisons Rotatives

11

Atomes Lourds

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A purified alkaloid fraction from Rauwolfia serpentina plants that depletes catecholamines from nerve endings, lowering blood pressure and heart rate, historically used in hypertension treatment. Like other rauwolfia alkaloids including reserpine, it has largely been replaced by newer antihypertensives with better side effect profiles.

Yes, Alseroxylon is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201454. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 62816. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Alseroxylon sur PillFYI

Structure

Données Clés

Formule: C11H28ClN5O

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.